The High Cost of Ignorance in Oncology

With this issue of Seminars in Oncology we experiment with a different approach. We move away from the traditional format of having an entire issue dedicated to one topic, to fewer papers focused on one topic. We dedicate a substantial effort to multiple myeloma (MM) an interesting disease whose treatment is evolving and bring you additional manuscripts covering interesting and timely topics. An example of the latter is the thought-provoking contribution form PHARMAC in New Zealand. At a time when discussions about drug costs leads to agreement “this trajectory is not sustainable” but provide no clear solutions, PHARMAC shows us what a society must do to deal with this problem.
Source: Seminars in Oncology - Category: Cancer & Oncology Authors: Source Type: research